Call Us Today! 1.800.928.7496
/, Interstitial Cystitis Network Blog/Cymbalta Discontinuation Syndrome

Cymbalta Discontinuation Syndrome

Have you ever struggled to reduce the dosage or just get off of an antidepressant? Did you struggle with profound side effects? IC patients trying to wean themselves off of Cymbalta have reported severe, devastating side effects. The FDA recently released an advisory about this syndrome. If you’ve taken it longer than four weeks and then stop or reduce the dosage, you could experience extreme mood swings, debilitating “brain zaps” and many physical and neurological symptoms that could “last for months.”

Tragically, many patients have been told that these symptoms were impossible and/or all in their heads. Now we know that it’s a real syndrome that the manufacturer, Lilly, does not appear to be taking seriously. One key problem is that the medication is only available in 30 or 60mg… thus making it very difficult to slowly wean yourself off of the medication.

If you are taking cymbalta or any of the similar antidepressants (i.e. effexor), you should read the following materials. Getting off these medications safely and without these side effects will take a lot of planning and work!

An excellent article by Dr. Christina Lasich MD

FDA Report – Cymbalta Discontinuation Syndrome

By |2013-11-13T12:44:35+00:00November 13th, 2013|Consumer Alerts, Interstitial Cystitis Network Blog|Comments Off on Cymbalta Discontinuation Syndrome

About the Author:

My Google Profile+ Jill Heidi Osborne is the president and founder of the Interstitial Cystitis Network, a health education company dedicated to interstitial cystitis, bladder pain syndrome and other pelvic pain disorders. As the editor and lead author of the ICN and the IC Optimist magazine, Jill is proud of the academic recognition that her website has achieved. The University of London rated the ICN as the top IC website for accuracy, credibility, readability and quality. (Int Urogynecol J - April 2013). Harvard Medical School rated both Medscape and the ICN as the top two websites dedicated to IC. (Urology - Sept 11). Jill currently serves on the Congressionally Directed Medical Research Panel (US Army) where she collaborates with researchers to evaluate new IC research studies for possible funding. Jill has conducted and/or collaborates on a variety of IC research studies on new therapeutics, pain care, sexuality, the use of medical marijuana, menopause and the cost of treatments, shining a light on issues that influence patient quality of life. An IC support group leader and national spokesperson for the past 20 years, she has represented the IC community on radio, TV shows, at medical conferences. She has written hundreds of articles on IC and its related conditions. With a Bachelors Degree in Pharmacology and a Masters in Psychology, Jill was named Presidential Management Intern (aka Fellowship) while in graduate school. (She was unable to earn her PhD due to the onset of her IC.) She spends the majority of her time providing WELLNESS COACHING for patients in need and developing new, internet based educational and support tools for IC patients, including the “Living with IC” video series currently on YouTube and the ICN Food List smartphone app! Jill was diagnosed with IC at the age of 32 but first showed symptoms at the age of 12.